Andreas Rummel, PhD
Andreas Rummel, PhD, is Senior Group Leader at the Institut für Toxikologie at the Medizinische Hochschule Hannover (MHH), Hannover, Germany. Dr Rummel obtained his PhD in biochemistry with the thesis, Characterization of the Cell Binding Domain of Clostridial Neurotoxins. In 2003, he joined the Institut für Toxikologie at MHH as a postdoctoral fellow, and in 2004, he joined toxogen GmbH, an enterprise developing clostridial neurotoxins as therapeutics and diagnostic tools.
Dr. Rummel has published 30 original peer-reviewed articles in top-tier journals and 8 reviews on the basic mechanisms of clostridial neurotoxins, and also edited the book Botulinum Neurotoxins. He has also served as reviewer for numerous journals, including Nature, PLoS One, and FEBS. In addition, Dr. Rummel is the inventor of 7 patent applications or granted patent families, respectively.
In 2006, Dr. Rummel received the start-up award Hochschul-Impuls, and was Scientific Sub-Committee Co-Chair of the TOXINS 2015 conference.